322 related articles for article (PubMed ID: 29851098)
21. Comparison of Coagulation Conditions in Patients With Liver Cirrhosis Due to Primary Sclerosing Cholangitis and Nonbiliary Causes of Cirrhosis Before Orthotopic Liver Transplant.
Najafi A; Jafarian A; Makarem J; Barzin G; Salimi J; Nasiri-Toosi M; Moini M; Ebrahimi A; Behboudi B; Mohammadpour Z; Shariat Moharari R
Exp Clin Transplant; 2020 Nov; 18(6):696-700. PubMed ID: 32552627
[TBL] [Abstract][Full Text] [Related]
22. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
23. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis?
Oshitani N; Jinno Y; Sawa Y; Nakamura S; Matsumoto T; Nishiguchi S; Seki S; Higuchi K; Arakawa T
Hepatogastroenterology; 2003; 50(54):1830-5. PubMed ID: 14696415
[TBL] [Abstract][Full Text] [Related]
24. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK
Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344
[TBL] [Abstract][Full Text] [Related]
25. Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography.
Oshitani N; Iimuro M; Kawashima D; Inagawa M; Sogawa M; Jinno Y; Yamagami H; Hamasaki N; Sawa Y; Hara J; Nakamura S; Matsumoto T; Seki S; Arakawa T; Kitano A; Kuroki T
Hepatogastroenterology; 2002; 49(44):317-21. PubMed ID: 11995441
[TBL] [Abstract][Full Text] [Related]
26. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
Poritz LS; Koltun WA
Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
[TBL] [Abstract][Full Text] [Related]
28. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
29. Ulcerative colitis--association with primary sclerosing cholangitis and colorectal neoplasia.
Leidenius M
Ann Chir Gynaecol; 1998; 87(1):72-3. PubMed ID: 9598240
[No Abstract] [Full Text] [Related]
30. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
31. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
32. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
33. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
34. Survival without biliary complications after liver transplant for primary sclerosing cholangitis.
Mogl MT; Albert K; Pascher A; Sauer I; Puhl G; Gül S; Schönemann C; Neuhaus P; Guckelberger O
Exp Clin Transplant; 2013 Dec; 11(6):510-21. PubMed ID: 24344944
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients.
Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N
J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia.
Kobayashi H; Miyano T; Horikoshi K; Tokita A
J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
Dold L; Nielsen MJ; Praktiknjo M; Schwarze-Zander C; Boesecke C; Schierwagen R; Mohr R; Wasmuth JC; Jansen C; Bischoff J; Rockstroh JK; Karsdal MA; Spengler U; Trebicka J; Leeming DJ
PLoS One; 2019; 14(7):e0219526. PubMed ID: 31295293
[TBL] [Abstract][Full Text] [Related]
38. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
39. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
[TBL] [Abstract][Full Text] [Related]
40. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
